Scopus BioPharma Inc. filed its 10-K on Apr 15, 2022 for the period ending Dec 31, 2021. In this report its auditor, Citrin Cooperman & Company, LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0021 USD | 0.00% | +90.91% | -95.13% |
1st Jan change | Capi. | |
---|---|---|
-95.13% | 88.38K | |
+8.05% | 113B | |
+10.29% | 106B | |
+0.41% | 22.27B | |
-12.06% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.74% | 17.24B | |
+7.23% | 14.29B | |
+36.63% | 12.52B |
- Stock Market
- Equities
- SCPS Stock
- News Scopus BioPharma Inc.
- Scopus BioPharma Inc. Auditor Raises 'Going Concern' Doubt